University of Southern California, Norris Comprehensive Cancer Center is a clinical research site located in Los Angeles, California, United States 90033.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Southern California, Norris Comprehensive Cancer Center has participated in 14 clinical trials with 7 currently active.
Therapeutic areas: NSCLC, Locally Advanced or Metastatic Non Small Cell Lung Cancer, Higher Risk Myelodysplastic Syndromes.
Sponsors: Eikon Therapeutics, Clovis Oncology, Inc., ALX Oncology Inc..
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Southern California, Norris Comprehensive Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Southern California, Norris Comprehensive Cancer Center has 14 clinical trials on record, with 7 currently active. Their work covers NSCLC, Locally Advanced or Metastatic Non Small Cell Lung Cancer, Higher Risk Myelodysplastic Syndromes.
Yes — University of Southern California, Norris Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.